QUIA — QuiaPEG Pharmaceuticals Holding AB Share Price
0.000.00%
Last trade - 00:00- SEK5.69m
- SEK26.20m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.37 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -101.71% | ||
| Return on Equity | -187.09% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | 1.86 | 0.22 | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
QuiaPEG Pharmaceuticals Holding AB is a Sweden-based biotechnology company. The Company develops improved versions of clinically validated biopharmaceutical drugs based on PEGylation technology platform. The Company’s technology is applicable on proteins, peptides and small molecules and offers a half-life extension platform consisting of covalent, as well as extended release PEGylation. The Company focuses on development of long-acting biopharmaceuticals for the treatment of metabolic disorders. The main project intends to reduce the frequent injection therapy by requiring significantly fewer injections. The Company offers out-licensing and partnering opportunities. It has a patent portfolio with patents pending and an approved the United States patent covering chemical linkers.
Directors
- Steen Kroyer CHM
- Marcus Bosson CEO
- Erik Magnusson CFO
- Jouni Tukiainen CEX (46)
- Cecilia Kemi COO
- Jonas Jarvius DRC (48)
- Christian Krog-Jensen DRC
- Marek Kwiatowski DRC
- Lars Linzander DRC (63)
- Johan von Kantzow DRC (46)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 18th, 2004
- Public Since
- June 21st, 2005
- No. of Employees
- 8
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 74,499,179
- Address
- Uppsala Business Park, UPPSALA, 754 50
- Web
- https://www.quiapeg.com/
- Phone
- +46 87780006
- Auditors
- BDO Malardalen AB
Upcoming Events for QUIA
Similar to QUIA
Biogaia AB
OMX Nordic Exchange Stockholm
BoneSupport Holding AB
OMX Nordic Exchange Stockholm
Calliditas Therapeutics AB
OMX Nordic Exchange Stockholm
Camurus AB
OMX Nordic Exchange Stockholm
Cline Scientific AB
OMX Nordic Exchange Stockholm
FAQ
What is the QuiaPEG Pharmaceuticals Holding AB share price?
As of Today at 22:52 UTC, shares in QuiaPEG Pharmaceuticals Holding AB are trading at SEK0.08. This share price information is delayed by 15 minutes.
How has the QuiaPEG Pharmaceuticals Holding AB share price performed this year?
Shares in QuiaPEG Pharmaceuticals Holding AB last closed at SEK0.08 and the price had moved by -95.61% over the past 365 days. In terms of relative price strength the QuiaPEG Pharmaceuticals Holding AB share price has underperformed the FTSE Global All Cap Index by -96.15% over the past year.
What are the analyst and broker recommendations for QuiaPEG Pharmaceuticals Holding AB?
There is no consensus recommendation for this security.
What is the QuiaPEG Pharmaceuticals Holding AB dividend yield?
QuiaPEG Pharmaceuticals Holding AB does not currently pay a dividend.
Does QuiaPEG Pharmaceuticals Holding AB pay a dividend?
QuiaPEG Pharmaceuticals Holding AB does not currently pay a dividend.
When does QuiaPEG Pharmaceuticals Holding AB next pay dividends?
QuiaPEG Pharmaceuticals Holding AB does not currently pay a dividend.
How do I buy QuiaPEG Pharmaceuticals Holding AB shares?
To buy shares in QuiaPEG Pharmaceuticals Holding AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of QuiaPEG Pharmaceuticals Holding AB?
As of the previous close price of SEK0.08, shares in QuiaPEG Pharmaceuticals Holding AB had a market capitalisation of SEK5.69m.
Where are QuiaPEG Pharmaceuticals Holding AB shares listed?
Here are the trading details for QuiaPEG Pharmaceuticals Holding AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: QUIA
What kind of share is QuiaPEG Pharmaceuticals Holding AB?
Based on an overall assessment of its quality, value and momentum QuiaPEG Pharmaceuticals Holding AB is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a QuiaPEG Pharmaceuticals Holding AB share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the QuiaPEG Pharmaceuticals Holding AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like QuiaPEG Pharmaceuticals Holding AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -24.28%.
As of the last closing price of SEK0.08, shares in QuiaPEG Pharmaceuticals Holding AB were trading -33.85% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the QuiaPEG Pharmaceuticals Holding AB PE Ratio?
The QuiaPEG Pharmaceuticals Holding AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of QuiaPEG Pharmaceuticals Holding AB?
QuiaPEG Pharmaceuticals Holding AB's management team is headed by:
- Steen Kroyer - CHM
- Marcus Bosson - CEO
- Erik Magnusson - CFO
- Jouni Tukiainen - CEX
- Cecilia Kemi - COO
- Jonas Jarvius - DRC
- Christian Krog-Jensen - DRC
- Marek Kwiatowski - DRC
- Lars Linzander - DRC
- Johan von Kantzow - DRC